Shionogi & Co., Ltd.
OTC: SGIOY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Isao Teshirogi
- Employees
- 4,955
- Headquarters
- Osaka, Japan
- IPO year
- 2015
- Market cap
- $14.8B
- Website
- https://www.shionogi.com
Loading SGIOY…
Loading profile data…Frequently asked questions about SGIOY
What does Shionogi & Co., Ltd. (SGIOY) do?
Shionogi & Co., Ltd. operates as a Japanese pharmaceutical enterprise, dedicated to the discovery, creation, manufacturing, and commercialization of a diverse array of medicines, diagnostic reagents, and medical equipment within Japan. The firm markets several key therapeutic agents, including Fetroja, a crucial therapy for multi-drug resistant...
Where does SGIOY trade?
Shionogi & Co., Ltd. (SGIOY) trades on the Other OTC.
What sector is SGIOY in?
Shionogi & Co., Ltd. (SGIOY) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shionogi & Co., Ltd.?
Isao Teshirogi is the chief executive officer of Shionogi & Co., Ltd. (SGIOY).
Where is Shionogi & Co., Ltd. headquartered?
Shionogi & Co., Ltd. is headquartered in Japan.
Does SGIOY pay a dividend?
Yes — Shionogi & Co., Ltd. (SGIOY) paid a trailing twelve-month dividend of USD 0.19 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SGIOY go public?
Shionogi & Co., Ltd. (SGIOY) completed its initial public offering in 2015.
Is SGIOY an ADR?
Yes — SGIOY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Shionogi & Co., Ltd. reporting and dividends follow the underlying issuer.